198 related articles for article (PubMed ID: 19874421)
21. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-alpha and dexamethasone.
Tirumurugaan KG; Kang BN; Panettieri RA; Foster DN; Walseth TF; Kannan MS
Respir Res; 2008 Mar; 9(1):26. PubMed ID: 18341691
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
24. MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells.
Thaikoottathil J; Chu HW
Mol Immunol; 2011 Dec; 49(3):415-22. PubMed ID: 21899893
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.
Verhoog NJ; Du Toit A; Avenant C; Hapgood JP
J Biol Chem; 2011 Jun; 286(22):19297-310. PubMed ID: 21474440
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
Fan P; Siwak DR; Abderrahman B; Agboke FA; Yerrum S; Jordan VC
Mol Cancer Ther; 2019 Oct; 18(10):1684-1695. PubMed ID: 31511352
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway.
Leis H; Page A; Ramírez A; Bravo A; Segrelles C; Paramio J; Barettino D; Jorcano JL; Pérez P
Mol Endocrinol; 2004 Feb; 18(2):303-11. PubMed ID: 14615607
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha and glucocorticoid receptor interaction in L6 muscle cells: a cooperative downregulation of myosin heavy chain.
Dekelbab BH; Witchel SF; DeFranco DB
Steroids; 2007 Sep; 72(9-10):705-12. PubMed ID: 17624386
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves.
Eicher SD; McMunn KA; Hammon HM; Donkin SS
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):115-25. PubMed ID: 15010221
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-21 enhances Toll-like receptor 2/4-mediated cytokine production via phosphorylation in the STAT3, Akt and p38 MAPK signalling pathways in human monocytic THP-1 cells.
Jian L; Sun L; Li C; Yu R; Ma Z; Wang X; Zhao J; Liu X
Scand J Immunol; 2019 Jun; 89(6):e12761. PubMed ID: 30977163
[TBL] [Abstract][Full Text] [Related]
32. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
33. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.
Ray KP; Farrow S; Daly M; Talabot F; Searle N
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):707-15. PubMed ID: 9371735
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of polymeric immunoglobulin receptor expression in flounder (Paralichthys olivaceus) gill cells by cytokine tumor necrosis factor-α via activating PI3K and NF-κB signaling pathways.
Sheng X; Guo Y; Tang Q; Tang X; Xing J; Chi H; Zhan W
Mol Immunol; 2021 Jul; 135():170-182. PubMed ID: 33901762
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids and Toll-like receptor 2 cooperatively induce acute-phase serum amyloid A.
Su Q; Weindl G
Pharmacol Res; 2018 Feb; 128():145-152. PubMed ID: 28941781
[TBL] [Abstract][Full Text] [Related]
36. TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.
Dendoncker K; Timmermans S; Vandewalle J; Eggermont M; Lempiäinen J; Paakinaho V; Van Hamme E; Dewaele S; Vandevyver S; Ballegeer M; Souffriau J; Van Wyngene L; Van Looveren K; Vanderhaeghen T; Beyaert R; De Bosscher K; Palvimo JJ; Van Montagu M; Libert C
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12942-12951. PubMed ID: 31182584
[TBL] [Abstract][Full Text] [Related]
37. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
Yoshida H; Jono H; Kai H; Li JD
J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348
[TBL] [Abstract][Full Text] [Related]
38. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling.
Su Q; Pfalzgraff A; Weindl G
J Steroid Biochem Mol Biol; 2017 Jul; 171():201-208. PubMed ID: 28377308
[TBL] [Abstract][Full Text] [Related]
39. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of mitogen-activated protein kinases and nuclear factor-κB signaling is involved in rapamycin suppression of TLR2-induced inflammatory response in monocytic THP-1 cells.
Sun R; Zhang Y; Ma S; Qi H; Wang M; Duan J; Ma S; Zhu X; Li G; Wang H
Microbiol Immunol; 2015 Oct; 59(10):614-22. PubMed ID: 26337526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
